Pharmacist Cardiovascular Podcast 45 credit minutes

Updated cholesterol guidelines introduce important changes in cardiovascular risk assessment and lipid management that directly impact pharmacist practice. This course reviews key updates from the new ACC/AHA dyslipidemia guideline, including risk assessment tools, LDL-C targets, and evolving roles for statin and nonstatin therapies. You will be better prepared to identify practice-relevant recommendations and support evidence-based lipid management in patient care.

Available in Subscription

This course is included in the following subscription:

Pharmacist CE Subscription

Pharmacist CE Subscription

Renewed Annually
$99.00 / year

Learning Objectives

Upon successful completion of this course, pharmacists should be able to:
1. Describe key pharmacist-relevant updates in the new ACC/AHA Guideline for the Management of Dyslipidemia.
2. Differentiate risk assessment and lipid-lowering treatment considerations that may influence pharmacist recommendations under the updated guideline.

Faculty

Rachel Maynard, PharmD

Disclosures:

Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.

Janelle Ruisinger, PharmD, FAPhA

Disclosures:

Janelle Ruisinger has no relevant financial relationships with ineligible companies to disclose.

Course Details